BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37722570)

  • 41. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
    Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
    Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus.
    Niemann I; Sunde L; Petersen LK
    Am J Obstet Gynecol; 2007 Jul; 197(1):45.e1-5. PubMed ID: 17618752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete hydatidiform mole in higher-order multiple pregnancies.
    Sileo FG; Giuliani GA; Facchinetti F; Contu G; Chiossi G; Bertucci E
    Minerva Obstet Gynecol; 2022 Jun; 74(3):308-313. PubMed ID: 35642715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastatic complete hydatidiform mole with a surviving coexistent twin. A case report.
    Kauffman DE; Sutkin G; Heine RP; Watt-Morse M; Price FV
    J Reprod Med; 1999 Feb; 44(2):131-4. PubMed ID: 10853445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
    Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
    Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The current situation of health services for hydatidiform mole in Cambodia.
    Yamamoto E; Kanal K; Soeung SC; Fujita N; Krang S; Long-Hay P; Nishino K; Niimi K; Hamajima N
    J Obstet Gynaecol Res; 2021 Oct; 47(10):3652-3660. PubMed ID: 34342367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gestational trophoblastic neoplasia after spontaneous normalization of human chorionic gonadotropin in patient with partial hydatidiform mole].
    Matos M; Ferraz L; Lopes Pde F; Lozoya C; Amim Junior J; Rezende-Filho J; Braga A
    Rev Bras Ginecol Obstet; 2015 Jul; 37(7):339-43. PubMed ID: 26247255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sonographic findings and perinatal outcome of multiple pregnancies associating a complete hydatiform mole and a live fetus: a case series.
    Kutuk MS; Ozgun MT; Dolanbay M; Batukan C; Uludag S; Basbug M
    J Clin Ultrasound; 2014 Oct; 42(8):465-71. PubMed ID: 24867873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twin pregnancy with a complete hydatidiform mole and surviving co-existent fetus.
    Piura B; Rabinovich A; Hershkovitz R; Maor E; Mazor M
    Arch Gynecol Obstet; 2008 Oct; 278(4):377-82. PubMed ID: 18273627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.